In-vitro approaches for cefiderocol susceptibility testing and interpretation in the context of recent Clinical & Laboratory Standards Institute advisory
- 4 June 2024
- journal article
- letter
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 50, 100622
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- New Perspectives on Antimicrobial Agents: CefiderocolAntimicrobial Agents and Chemotherapy, 2021
- Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth MicrodilutionJournal of Clinical Microbiology, 2020
- Cefiderocol Antimicrobial Susceptibility Testing Considerations: the Achilles' Heel of the Trojan Horse?Journal of Clinical Microbiology, 2020
- Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection ModelAntimicrobial Agents and Chemotherapy, 2019